Published in J Clin Oncol on November 01, 1998
How do distress and well-being relate to medical student empathy? A multicenter study. J Gen Intern Med (2007) 2.10
Who should measure quality of life? BMJ (2001) 1.83
Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. J Pain Symptom Manage (2007) 1.83
The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer (2006) 1.47
Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare®) for chemotherapy-induced peripheral neuropathy. J Pain Symptom Manage (2010) 1.39
Reliability and validity of the Functional Assessment of Chronic Illness Therapy-Palliative care (FACIT-Pal) scale. J Pain Symptom Manage (2008) 1.16
Measuring the symptom burden associated with the treatment of chronic myeloid leukemia. Blood (2013) 1.14
Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer. J Thorac Oncol (2009) 1.12
Extending basic principles of measurement models to the design and validation of Patient Reported Outcomes. Health Qual Life Outcomes (2006) 1.10
Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer. Cancer (2010) 1.03
Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03. J Neurooncol (2009) 0.91
Sleep and quality of life in long-term lung cancer survivors. Lung Cancer (2007) 0.89
Safety of liver resection and effect on quality of life in patients with benign hepatic disease: single center experience. BMC Surg (2011) 0.88
Antecedents of global decline in health-related quality of life among middle-aged African Americans. J Gerontol B Psychol Sci Soc Sci (2009) 0.87
Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales. Health Qual Life Outcomes (2014) 0.87
Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA. J Clin Oncol (2008) 0.86
Impact of cancer occurrence on health-related quality of life: a longitudinal pre-post assessment. Health Qual Life Outcomes (2004) 0.85
Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer. Gynecol Oncol (2013) 0.85
The symptom burden of treatment-naive patients with head and neck cancer. Cancer (2014) 0.84
Bilateral transfemoral/transtibial amputations due to battle injuries: a comparison of Vietnam veterans with Iraq and Afghanistan servicemembers. Clin Orthop Relat Res (2014) 0.82
Assessment of patient-reported measures of bowel function before and after pelvic radiotherapy: an ancillary study of the North Central Cancer Treatment Group study N00CA. Support Care Cancer (2012) 0.82
Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1. Support Care Cancer (2013) 0.82
Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists. BMC Cancer (2010) 0.81
Health-related quality-of-life findings for the prostate cancer prevention trial. J Natl Cancer Inst (2012) 0.81
Long-term quality of life after hepatic resection: health is not simply the absence of disease. World J Surg (2009) 0.81
Comparing and Validating Simple Measures of Patient-Reported Peripheral Neuropathy for Oncology Clinical Trials: NCCTG N0897 (Alliance) A Pooled Analysis of 2440 Patients. SOJ Anesthesiol Pain Manag (2015) 0.78
Wherefore global quality-of-life assessment? J Clin Oncol (1999) 0.77
A pilot study assessing social support among cancer patients enrolled on clinical trials: a comparison of younger versus older adults. Cancer Manag Res (2010) 0.76
A randomized controlled trial studying the effectiveness of group medical appointments on self-efficacy and adherence in sickle cell disease (TEAM study): study protocol. BMC Hematol (2016) 0.75
Predictors of health-related quality of life and association with survival may identify colorectal cancer patients at high risk of poor prognosis. Qual Life Res (2016) 0.75
Electronic monitoring of symptoms and syndromes associated with cancer: methods of a randomized controlled trial SAKK 95/06 E-MOSAIC. BMC Palliat Care (2012) 0.75
Chemotoxicity recurrence in older patients: Risk factors and effectiveness of preventive strategies-a prospective study. Cancer (2015) 0.75
A brief assessment of physical functioning for prostate cancer patients. Patient Relat Outcome Meas (2010) 0.75
Outcome research in palliative care: could it represent a new dimension of clinical research or clinical practice? Support Care Cancer (2004) 0.75
Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA (1993) 3.91
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst (1999) 3.46
The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med (1986) 3.27
It is now the age to define the appropriate follow-up of primary breast cancer patients. J Clin Oncol (1994) 3.00
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst (2001) 2.90
Methodologic lessons learned from hot flash studies. J Clin Oncol (2001) 2.82
Megestrol acetate for the prevention of hot flashes. N Engl J Med (1994) 2.72
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med (1979) 2.63
Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol (2000) 2.11
Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int (2007) 1.83
Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol (1990) 1.74
Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases. Cancer (2001) 1.70
Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma. J Clin Oncol (1998) 1.65
Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg (1993) 1.64
Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther (2011) 1.62
Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value. J Neurosurg (1997) 1.58
Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. J Neurosurg (1993) 1.55
Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy? Int J Radiat Oncol Biol Phys (1995) 1.51
The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer (1986) 1.50
Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial. Int J Radiat Oncol Biol Phys (1996) 1.50
Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma. J Clin Oncol (1984) 1.46
Continuous intravenous infusion of morphine sulfate for control of severe pain in children with terminal malignancy. J Pediatr (1980) 1.45
2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol (2000) 1.43
Soy for breast cancer survivors: a critical review of the literature. J Nutr (2001) 1.43
Increasing the proportion of women in academic medicine: one institution's response. Mayo Clin Proc (1999) 1.42
Policies for study monitoring and interim reporting of results. J Clin Oncol (1987) 1.41
An update: cancer-associated anorexia as a treatment target. Curr Opin Clin Nutr Metab Care (2001) 1.40
Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol (1999) 1.39
Stopping when the experimental regimen does not appear to help. Stat Med (1994) 1.37
Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol (1991) 1.33
Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol (1994) 1.33
Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys. J Med Genet (2005) 1.29
Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol (1998) 1.29
Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis. Breast Cancer Res Treat (1999) 1.27
Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma. J Neurosurg (1995) 1.25
Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results. J Neurosurg (1998) 1.24
Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations. Clin Cancer Res (1999) 1.23
Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome. N Engl J Med (1992) 1.22
Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer. J Clin Oncol (1994) 1.18
Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer. J Clin Oncol (1994) 1.18
Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg (1989) 1.16
Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys (1996) 1.16
Definitions of hot flashes in breast cancer survivors. J Pain Symptom Manage (1998) 1.15
Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas. JAMA (1995) 1.15
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo. Ann Intern Med (1979) 1.14
Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens (2000) 1.12
A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index. J Clin Oncol (2001) 1.12
Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Genes Chromosomes Cancer (1992) 1.11
Resection for solitary brain metastasis. Role of adjuvant radiation and prognostic variables in 229 patients. J Neurosurg (1992) 1.09
Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer. J Urol (1999) 1.08
Transdermal clonidine for ameliorating post-orchiectomy hot flashes. J Urol (1994) 1.08
Induction of adrenal suppression by megestrol acetate. Ann Intern Med (1996) 1.07
Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J Clin Oncol (1994) 1.07
Megestrol acetate-induced adrenal suppression. J Clin Oncol (1996) 1.06
DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma. Cancer (1991) 1.05
Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors. J Clin Oncol (1999) 1.05
Supratentorial pilocytic astrocytomas. A clinicopathologic, prognostic, and flow cytometric study of 51 patients. Cancer (1993) 1.05
Adjuvant radiation therapy after surgical resection of solitary brain metastasis: association with pattern of failure and survival. Int J Radiat Oncol Biol Phys (1987) 1.04
Genes and lifestyle factors in obesity: results from 12,462 subjects from MONICA/KORA. Int J Obes (Lond) (2010) 1.04
Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. Cancer (1996) 1.03
Oligodendrogliomas: the Mayo Clinic experience. J Neurosurg (1992) 1.03
A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma. Cancer (2001) 1.02
The prevalence of pain in a pediatric and young adult cancer population. Pain (1987) 1.01
Follow-up testing for curatively treated cancer survivors. What to do? JAMA (1995) 0.99
Radiotherapeutic considerations in the treatment of hemangioblastomas of the central nervous system. Int J Radiat Oncol Biol Phys (1990) 0.99
Supratentorial gliomas: a comparative study by grade and histologic type. J Neurooncol (1997) 0.99
Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation. Int J Oncol (1999) 0.98
A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia. Cancer (1990) 0.97
The clinical significance of nuclear DNA ploidy pattern in 184 patients with pheochromocytoma. Cancer (1992) 0.97
Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients. J Clin Oncol (1997) 0.96
Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes. Cancer (1998) 0.96
Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma. J Clin Oncol (1993) 0.96
Continuous subcutaneous infusion of morphine in children with cancer. Am J Dis Child (1983) 0.96
Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment Group. Am J Clin Oncol (1999) 0.96
Variation in morphine pharmacokinetics in children with cancer. Dev Pharmacol Ther (1985) 0.95
Phase II evaluation of infusional etoposide and cisplatin in patients with recurrent astrocytoma. J Neurooncol (1990) 0.95
Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. J Clin Oncol (1995) 0.95
A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics. Support Care Cancer (1995) 0.94
A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors. Cancer (2001) 0.94
Astrocytomas of the cerebellum. A comparative clinicopathologic study of pilocytic and diffuse astrocytomas. Cancer (1993) 0.93
Complete responders to chemotherapy in metastatic breast cancer. Characterization and analysis. JAMA (1979) 0.93
Primary central nervous system non-Hodgkin's lymphoma (PCNSL): survival advantages with combined initial therapy? A final report of the North Central Cancer Treatment Group (NCCTG) Study 86-72-52. Int J Radiat Oncol Biol Phys (1999) 0.92
Septicemia in childhood malignancy. Analysis of 101 consecutive episodes. Clin Pediatr (Phila) (1981) 0.91
Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study. J Clin Oncol (1996) 0.91